Dren Bio
Clinical trials sponsored by Dren Bio, explained in plain language.
-
New drug trial aims to regrow hair and restore skin color
Disease control Recruiting nowThis early-stage study is testing an experimental drug called DR-01 in adults with alopecia areata (hair loss) or vitiligo (skin depigmentation). The main goal is to check the drug's safety and see if it shows any signs of helping regrow hair or restore skin color. Researchers wi…
Phase: PHASE1 • Sponsor: Dren Bio • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New drug tested for Tough-to-Treat blood cancers
Disease control Recruiting nowThis is the first study in people to test an experimental drug called DR-01 for adults with rare and aggressive blood cancers, including large granular lymphocytic leukemia (LGLL) and several types of cytotoxic lymphomas. The main goals are to find a safe dose and see if the drug…
Phase: PHASE1, PHASE2 • Sponsor: Dren Bio • Aim: Disease control
Last updated Mar 11, 2026 14:54 UTC
-
New drug tested for Tough-to-Treat cancers
Disease control Recruiting nowThis is an early-stage study to check the safety and initial activity of an experimental drug called DR-0202. It is for adults with advanced cancers that have spread, returned, or stopped responding to at least two prior treatments. The main goal is to find a safe dose and see ho…
Phase: PHASE1 • Sponsor: Dren Bio • Aim: Disease control
Last updated Mar 02, 2026 15:27 UTC